References:
1. APA Work Group on Alzheimer’s Disease and other Dementias, Rabins PV, Blacker D, Rovner BW, et al.; Steering Committee on Practice Guidelines, McIntyre JS, Charles SC, Anzia DJ, et al. American Psychiatric Association practice guideline for the treatment of patients with Alzheimer’s disease and other dementias, 2nd edition. Am J Psychiatry 2007; 164 (12 Suppl): 5–56.
2. Grossberg GT, Desai AK. Management of Alzheimer’s disease. J Gerontol A Biol Sci Med Sci 2003; 58 (4): 331–353.
3. Rabins PV, Rovner BW, Rummans T, et al. Guideline Watch (October 2014): practice guideline for the treatment of patients with Alzheimer’s disease and other dementias. Focus (Am Psychiatr Publ) 2017; 15 (1): 110–128.
4. Schmidt R, Hofer E, Bouwman FH, et al. EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer’s disease. Eur J Neurol 2015; 22 (6): 889–898.
